Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2016

Open Access 01-12-2016 | Research article

Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication

Authors: Joanna Moncrieff, Kiran Azam, Sonia Johnson, Louise Marston, Nicola Morant, Katherine Darton, Neil Wood

Published in: BMC Psychiatry | Issue 1/2016

Login to get access

Abstract

Background

Government policy encourages increasing involvement of patients in their long-term care. This paper describes the development and pilot evaluation of a ‘Medication Review Tool’ designed to assist people to participate more effectively in discussions about antipsychotic drug treatment.

Methods

The Medication Review Tool developed consisted of a form to help patients identify pros and cons of their current antipsychotic treatment and any desired changes. It was associated with a website containing information and links about antipsychotics. For the trial, participants diagnosed with psychotic disorders were recruited from community mental health services. Cluster randomisation was used to allocate health professionals (care co-ordinators) and their associated patients to use of the Medication Review Tool or usual care. All participants had a medical consultation scheduled, and those in the intervention group completed the Medication Review Tool, with the help of their health professional prior to this, and took the completed Form into the consultation. Two follow-up interviews were conducted up to three months after the consultation. The principal outcome was the Decision Self Efficacy Scale (DSES). Qualitative feedback was collected from patients in the intervention group.

Results

One hundred and thirty patients were screened, sixty patients were randomised, 51 completed the first follow-up assessment and 49 completed the second. Many patients were not randomised due to the timing of their consultation, and involvement of health professionals was inconsistent. There was no difference between the groups on the DSES (-4.16 95 % CI -9.81, 1.49), symptoms, side effects, antipsychotic doses or patient satisfaction. Scores on the Medication Adherence Questionnaire indicated an increase in participants’ reported inclination to adherence in the intervention group (coefficient adjusted for baseline values -0.44; 95 % CI -0.76, -0.11), and there was a small increase in positive attitudes to antipsychotic medication (Drug Attitude Inventory, adjusted coefficient 1.65; 95 % CI -0.09, 3.40). Qualitative feedback indicated patients valued the Tool for identifying both positive and negative aspects of drug treatment.

Conclusions

The trial demonstrated the design was feasible, although challenges included service re-configurations and maintaining health professional involvement. Results may indicate a more intensive and sustained intervention is required to facilitate participation in decision-making for this group of patients.

Trial registration

Current controlled trials ISRCTN12055530, Retrospectively registered 9/12/2013.
Literature
1.
Department of Health. Our Health, Our Care, Our Say. London: Department of Health; 2006.
2.
Shepherd G, Boardman J, Slade M. Making Recovery a Reality. London: Sainsbury Centre for Mental Health; 2008.
3.
Deegan PE, Drake RE. Shared decision making and medication management in the recovery process. Psychiatr Serv. 2006;57:1636–9.CrossRefPubMed
4.
Stacey D, Legare F, Col NF, Bennett CL, Barry MJ, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1:CD001431.PubMed
5.
Healthcare Commission. Talking about medicines: The management of medicines in Trusts providing mental health services. London: Commission for Healthcare, Audit and Inspection; 2007.
6.
National Institute for Mental Health England National Workforce Programme. Medicines Management: Everybody’s Business. A guide for service users, carers, and health and social care practitioners. London: Department of Health; 2008.
7.
Leucht S, Arbter D, Engel RR, Kissling W, Davis JM. How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Mol Psychiatry. 2009;14:429–47.
8.
Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet. 2012;379:2063–71.CrossRefPubMed
9.
Moncrieff J, Cohen D, Mason JP. The subjective experience of taking antipsychotic medication: a content analysis of Internet data. Acta Psychiatr Scand. 2009;120:102–11.CrossRefPubMed
10.
Barbui C, Nose M, Bindman J, Schene A, Becker T, Mazzi MA, et al. Sex differences in the subjective tolerability of antipsychotic drugs. J Clin Psychopharmacol. 2005;25:521–6.CrossRefPubMed
11.
Sun SX, Liu GG, Christensen DB, Fu AZ. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Curr Med Res Opin. 2007;23:2305–12.CrossRefPubMed
12.
Seale C, Chaplin R, Lelliott P, Quirk A. Antipsychotic medication, sedation and mental clouding: an observational study of psychiatric consultations. Soc Sci Med. 2007;65:698–711.CrossRefPubMed
13.
Hofer A, Kemmler G, Eder U, Edlinger M, Hummer M, Fleischhacker WW. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. J Clin Psychiatry. 2004;65:932–9.CrossRefPubMed
14.
Hamann J, Mendel RT, Fink B, Pfeiffer H, Cohen R, Kissling W. Patients’ and psychiatrists’ perceptions of clinical decisions during schizophrenia treatment. J Nerv Ment Dis. 2008;196:329–32.CrossRefPubMed
15.
National Institute for Health and Care Excellence. Psychosis and schizophrenia in adults: treatment and management. London: NICE; 2014.
16.
Hamann J, Cohen R, Leucht S, Busch R, Kissling W. Do patients with schizophrenia wish to be involved in decisions about their medical treatment? Am J Psychiatry. 2005;162:2382–4.CrossRefPubMed
17.
Loh A, Kremer N, Giersdorf N, Jahn H, Hanselmann S, Bermejo I, et al. Information and participation interests of patients with depression in clinical decision making in primary care. Z Arztl Fortbild Qualitatssich. 2004;98:101–7.PubMed
18.
Loh A, Simon D, Wills CE, Kriston L, Niebling W, Harter M. The effects of a shared decision-making intervention in primary care of depression: a cluster-randomized controlled trial. Patient Educ Couns. 2007;67:324–32.CrossRefPubMed
19.
Hamann J, Langer B, Winkler V, Busch R, Cohen R, Leucht S, et al. Shared decision making for in-patients with schizophrenia. Acta Psychiatr Scand. 2006;114:265–73.CrossRefPubMed
20.
Hamann J, Mendel R, Meier A, Asani F, Pausch E, Leucht S, et al. “How to speak to your psychiatrist”: shared decision-making training for inpatients with schizophrenia. Psychiatr Serv. 2011;62:1218–21.CrossRefPubMed
21.
van der Krieke L, Emerencia AC, Boonstra N, Wunderink L, de Jonge P, Sytema S. A web-based tool to support shared decision making for people with a psychotic disorder: randomized controlled trial and process evaluation. J Med Internet Res. 2013;15:e216.CrossRefPubMedPubMedCentral
22.
Woltmann EM, Wilkniss SM, Teachout A, McHugo GJ, Drake RE. Trial of an electronic decision support system to facilitate shared decision making in community mental health. Psychiatr Serv. 2011;62:54–60.CrossRefPubMed
23.
Stovell D, Morrison AP, Panayiotou M, Hutton P. Shared treatment decision-making and empowerment-related outcomes in psychosis: systematic review and meta-analysis. Br J Psychiatry. 2016: doi:10.​1192/​bjp.​bp.​114.​158931
24.
25.
26.
Bunn H, O’Connor A. Validation of client decision-making instruments in the context of psychiatry. Can J Nurs Res. 1996;28:13–27.PubMed
27.
Atkisson CC, Zwick R. The Client Satisfaction Questionnaire: Psychometric properties and correlations with service utilisation and psychotherapy outcome. Eval Program Plan. 1982;5:233–7.CrossRef
28.
Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med. 1983;13:177–83.CrossRefPubMed
29.
Day JC, Wood G, Dewey M, Bentall RP. A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. Br J Psychiatry. 1995;166:650–3.CrossRefPubMed
30.
Yamamoto N, Inada T, Shimodera S, Morokuma I, Furukawa TA. Brief PANSS to assess and monitor the overall severity of schizophrenia. Psychiatry Clin Neurosci. 2010;64:262–7.CrossRefPubMed
31.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.CrossRefPubMed
32.
Adams J, Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand. 2000;101:119–24.CrossRefPubMed
33.
Corp IBM. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp; 2013.
34.
Stata Statistical Software: Release 13. College Station, Tx: StataCopr LP; 2013.
35.
Braun V, Clark V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.CrossRef
Metadata
Title
Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication
Authors
Joanna Moncrieff
Kiran Azam
Sonia Johnson
Louise Marston
Nicola Morant
Katherine Darton
Neil Wood
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2016
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-016-0921-7

Other articles of this Issue 1/2016

BMC Psychiatry 1/2016 Go to the issue

Research article

Psychotic relapse and associated factors among patients attending health services in Southwest Ethiopia: a cross-sectional study

Research article

Spatial suicide clusters in Australia between 2010 and 2012: a comparison of cluster and non-cluster among young people and adults

Research article

Associations between personality disorder characteristics and treatment outcomes in people with co-occurring alcohol misuse and depression

Study protocol

A pragmatic randomized control trial and realist evaluation on the implementation and effectiveness of an internet application to support self-management among individuals seeking specialized mental health care: a study protocol

Research article

The latent structure of post-traumatic stress disorder among Arabic-speaking refugees receiving psychiatric treatment in Denmark

Research article

The assessment of depression in people with multiple sclerosis: a systematic review of psychometric validation studies